%0 Journal Article
%T 经内镜逆行胰胆管造影术后胰腺炎研究进展<br>Research Progress of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography
%A 朱成龙
%A 陈俊卯
%J Asian Case Reports in Emergency Medicine
%P 103-108
%@ 2328-0395
%D 2025
%I Hans Publishing
%R 10.12677/acrem.2025.131016
%X 胰腺炎是经内镜逆行胰胆管造影术(ERCP)术后最常见的并发症&#65292;在ERCP发展的几十年中一直有着较高的发病率&#65292;严重影响患者的术后恢复。本文综述了术后胰腺炎的发病机制、危险因素以及用于预防及术后胰腺炎的各种药物和手术方法&#65292;以改善内窥镜逆行胰胆管造影术后患者的预后。<br>Pancreatitis is the most common complication after Endoscopic Retrograde Cholangiopancreatography (ERCP). It has a high incidence rate in the decades of ERCP development, which seriously affects the postoperative recovery of patients. This article reviews the pathogenesis, risk factors, and various drugs and surgical methods used for the prevention and treatment of postoperative pancreatitis, to improve the prognosis of patients after endoscopic retrograde cholangiopancreatography.
%K 经内镜逆行胰胆管造影术&#65292
%K ERCP术后胰腺炎&#65292
%K 生长抑素&#65292
%K 非甾体抗炎药&#65292
%K 加贝酯&#65292
%K 甲磺酸萘莫司他&#65292
%K 乌司他丁&#65292
%K 他克莫司<br>Endoscopic Retrograde Cholangiopancreatography
%K Post-ERCP Pancreatitis
%K Somatostatin
%K Non-Steroidal Anti-Inflammatory Drugs
%K Gabelate
%K Napalmostat Mesylate
%K Ulinastatin
%K Tacrolimus
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=107646